Wells Fargo & Company Revelation Biosciences, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.18 - $431.55 $0 - $1,726
4 Added 3.48%
119 $0
Q3 2022

Nov 14, 2022
BUY
$0.09 - $1438.5 $7 - $112,203
78 Added 210.81%
115 $0
Q2 2022

Aug 12, 2022
BUY
$448.98 - $1344.0 $2,244 - $6,720
5 Added 15.63%
37 $0
Q1 2022

May 16, 2022
BUY
$971.04 - $11077.5 $31,073 - $354,480
32 New
32 $0

Others Institutions Holding REVB

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About REVELATION BIOSCIENCES, INC.

REVB Quotes by TradingView
  • Ticker REVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,525,800
  • Market Cap $17.4M
  • Description
  • Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the prevention or treatment of chronic nasal conge...
More about REVB
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email